Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.36 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25329390 | 0.85 | ALOX15 (0.46) | ALOX15ALOX12MCL1ALDH1A1TSHR | |
| SCHEMBL16736937 | 0.81 | RXRA (0.41) | ALOX15ALOX12ALDH1A1TSHRIDO1 | |
| SCHEMBL30356445 | 0.79 | HMGCR (0.53) | MCL1ALDH1A1HMGCRTAAR1 | |
| SCHEMBL785200 | 0.79 | HMGCR (0.53) | MCL1ALDH1A1HMGCRTAAR1 | |
| SCHEMBL25329407 | 0.79 | ALDH1A1 (0.40) | ALOX15ALOX12MCL1ALDH1A1HMGCR | |
| SCHEMBL25329769 | 0.79 | MAPT (0.44) | ALOX15ALOX12ALDH1A1TSHRIDO1 | |
| SCHEMBL16736924 | 0.79 | ALOX15 (0.43) | ALOX15ALOX12ALDH1A1TSHRIDO1 | |
| SCHEMBL15576314 | 0.79 | RXRA (0.36) | ALDH1A1TSHRFFAR4FFAR1TAAR1 | |
| SCHEMBL25329894 | 0.78 | ESR1 (0.44) | ALOX15MCL1ALDH1A1TSHRHMGCR | |
| SCHEMBL16736894 | 0.76 | HTR2A (0.35) | ALOX15ALOX12ALDH1A1TSHRIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583813-B2 | Polymerization inhibitors | BASF SE (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | RCE1, CABLES1, DPYD | ALOX15 2186/4885ALOX12 1986/4885MCL1 2401/4885 |
| US-12583813-B2 | Polymerization inhibitors | PTGS1, PTGER1, POT1 | ALOX15 615/4885ALOX12 211/4885MCL1 1346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.